Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration | Budzinskaya | Ophthalmology in Russia

Ophthalmology in Russia
Oftalʹmologiâ

ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)

eng | рус

Preview

Ophthalmology in Russia

Advanced search

Archives

Download this PDF file

For citations:

Budzinskaya M.V., Plyukhova A.A., Andreeva Yu.S., Kurguzova A.G., Budzinskaya K.A. Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration. Ophthalmology in Russia. 2022;19(4):849-856. (In Russ.) https://doi.org/10.18008/1816-5095-2022-4-849-856

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)

* not an advertisement

Editor-in-Chief

Trubilin V.N

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. V. Budzinskaya
Krasnov Scientific Research Institute of Eye Diseases
Russian Federation

MD, head of the Retina and optic nerve pathology department

Rossolimo str., 11A, B, Moscow, 119021, Russian Federation

A. A. Plyukhova
Krasnov Scientific Research Institute of Eye Diseases
Russian Federation

PhD, research officer of the Retina and optic nerve pathology department

Rossolimo str., 11A, B, Moscow, 119021, Russian Federation

Yu. S. Andreeva
Krasnov Scientific Research Institute of Eye Diseases
Russian Federation

postgraduate of the Retina and optic nerve pathology department

Rossolimo str., 11A, B, Moscow, 119021, Russian Federation

A. G. Kurguzova
Krasnov Scientific Research Institute of Eye Diseases
Russian Federation

PhD, research officer of the the Retina and optic nerve pathology department

Rossolimo str., 11A, B, Moscow, 119021, Russian Federation

K. A. Budzinskaya
Pirogov Russian National Research Medical University
Russian Federation

student

Ostrovityanova str., 1, Moscow, 117997, Russian Federation

Notifications